← Back
$NBIX All transactions

NEUROCRINE BIOSCIENCES INC

▼ SELL 10b5-1 Plan

$ Value

$2.7M

Shares

18,000

Price

$152

Filed

Nov 6

Insider

Name

RASTETTER WILLIAM H

Title

CIK

0001205903

Roles

Director

Transaction Details

Transaction Date

2025-11-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,360

Footnotes

The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on August 6, 2025. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. | Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $153.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | 40,360 of the reported shares are held by the Rastetter Family Trust established September 2, 2010, of which the Reporting Person has voting and investment power. | The option was granted May 20, 2016 and vested in 12 equal monthly installments beginning June 20, 2016. These options were due to expire on May 20, 2026.

Filing Info

Accession No.

0001205903-25-000005

Form Type

4

Issuer CIK

0000914475

RASTETTER WILLIAM H's History

Date Ticker Type Value
2025-11-05 NBIX M $862K
2025-11-05 NBIX $2.7M
2025-11-05 NBIX M $0
2025-07-09 DARE A $0
2025-06-25 RGLS U
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-25 RGLS D

Other Insiders at NBIX (90d)

Insider Bought Sold Last
GORMAN KEVIN CHARLES 2026-02-13
Lippoldt Darin
Chief Legal Officer
2026-02-13
Gano Kyle
Chief Executive Officer
2026-02-13
BENEVICH ERIC
Chief Commercial Officer
2026-02-13
ABERNETHY MATT
Chief Financial Officer
2026-03-04
Cooke Julie
Chief Human Resources Officer
2026-02-13
Keswani Sanjay Chandru
Chief Medical Officer
2026-02-13
Onyia Jude
Chief Scientific Officer
2026-02-20
Boyer David W.
Chief Corp. Affairs Officer
2026-02-13
Delaet Ingrid
Chief Regulatory Officer
2026-02-13